Intro to Birmingham Health Partners
Birmingham Health Partners (BHP) is a cluster of contrasting, yet complementary organisations, sharing the common goal of achieving health and economic impact through the purposeful use of knowledge and expertise.
It is a strategic alliance between the University of Birmingham, the West Midlands Academic Health Science Network, and two NHS Foundation Trusts – Birmingham Women’s & Children’s, and University Hospitals Birmingham. Our members collaborate to bring healthcare innovations through to clinical application.
Its unique ecosystem enables the full spectrum of translational medicine: encompassing health data; an established local health system; academic excellence; and an extensive clinical trials capability.
Pioneering and life-changing work takes place across a number of leading facilities, including the Institute of Translational Medicine. We are supporting the development of Birmingham Health Innovation Campus, which will enable productive interactions between clinicians, academics, industry and patients to accelerate the field of personalised, precision medicine.
By enabling integrated, multidisciplinary working, BHP helps bring about answers to complex healthcare issues for the direct benefit of people worldwide.
Our purpose is to bring healthcare innovations rapidly to clinical application, by harnessing the collaborative research strengths of the University, NHS and industry.
Our work is informed by a dynamic strategy that enables our organisations and our people to adapt and respond swiftly to changing circumstances.
Our value principles
We are greater than the sum of our parts: our inclusive, multidisciplinary teams combine their expertise at all stages of research, development and implementation
We are advancing patient care by combining the latest technology with a wide variety of scientific disciplines, to pioneer world-leading solutions to global health issues
Through our partnership, research becomes reality. New treatments are brought from the lab directly through to clinical adoption, reaching patients faster